Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Rogier Hintzen, Michelle Mellion et al.|The Lancet Neurology|2019Cited by 185
Specific impairments in visual processing following lesion side in hemianopic patientsCéline Cavézian, Sylvie Chokron, Isabelle Gaudry et al.|Cortex|2009Cited by 39
Œdèmes papillaires bilatéraux : étude prospective de 50 patientsRomain Deschamps, Olivier Gout, Caroline Dehais et al.|Revue Neurologique|2008Cited by 10
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisMathilde Lefort, F. Grand’Maison, Sifat Sharmin et al.|BMC Medical Research Methodology|2022Cited by 6
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and ProgressionMarianna Cortese, Tuula Pirttilä, Xiaojing Peng et al.|Neurology|2025Cited by 3